Our technology platform is based on the idea that we can develop better products by combining biological molecules with desired properties into one product called fusion enzymes. We design and construct fusion enzymes based on industrial process parameters. That means our enzymes are designed to work in a commercial process and by combining desired activities into one molecule reduces manufacturing and operating costs.

In fact our technology is partially funded by the Department of Energy (DoE). C2 Biotechnologies, LLC was just awarded a Phase I Small Business Innovative Research (SBIR) grant for $100,000. Over the course of 9 months we will use our technology platform to construct a cellulosic fusion enzyme.

We are currently looking for a commercialization partner. Our goal is to become a bio-manufacturing facility located in the Hudson Valley. We are seeking a commercialization partner(s) that have potential fusion enzyme cliental on line and can offer our products through various marketing and distribution channels